NCT00456183View on ClinicalTrials.gov

Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

April 30, 2007

Conditions
Tuberculosis
Interventions
BIOLOGICAL

MVA 85A

Trial Locations (1)

OX3 7LJ

Centre for Clinical Vaccinology and Tropical Medicine, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT00456183 - Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB. | Biotech Hunter | Biotech Hunter